12:00 AM
Aug 05, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BIND-014: Phase II started

Bind began an open-label, U.S. Phase II trial to evaluate BIND-014 in 40 patients with stage III/IV NSCLC who have failed 1 prior platinum-containing...

Read the full 98 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >